March 27 (Reuters) - Bausch + Lomb ( BLCO ) said on

Thursday it will recall some of its implantable eye lenses after

receiving reports of complications, the cause of which could not

immediately be known.

The company said it is recalling these lenses, which are

part of its enVista platform, out of an abundance of caution,

and was looking to identify a root cause.

"As much as we believe in the enVista platform, patient

safety will always be our number one priority," said CEO Brent

Saunders.

The company's intraocular or surgically implanted lenses are

used in cataract surgery to replace the natural clouded lens in

the eye.

Bausch + Lomb ( BLCO ) said there have been reports of an

inflammatory reaction in some patients with these lenses, adding

the patients responded quickly to treatment, with none requiring

removal of the lens.

The company said it is informing eye care professionals

about the impacted lots and return protocols for the product.